Mitochondrial replacement techniques, Mexico and the legal unknowns
By César Palacios-González,
BioNews
| 04. 24. 2017
It is not every day that we can examine the details of the first use of a new reproductive technology. But the first live birth of a baby following the use of a mitochondrial replacement technique (MRT) in IVF last year gives a window into just this. The case (see BioNews 895) – with procedures carried out in both the US and Mexico – also raises legal questions.
The birth garnered a huge amount of attention after New Scientist magazine broke the news last September. MRT is a technique that aids women affected by a heritable mitochondrial disease to have genetically-related children free from mitochondrial DNA (mtDNA) disorders. These cause neuromuscular diseases that can have devastating effects, including heart and major organ failure, dementia, stroke, blindness, deafness, infant encephalopathy, and premature death.
From the moment the news broke until a paper detailing the case was published on 3 April this year (see BioNews 895), the only technical information we had about this experimental procedure came from three sources: a short conference abstract, press interviews...
Related Articles
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Isabelle Bartram
| 07.17.2024
Image by Kuzzat Altay from Unsplash
Uyghurs, a predominantly Muslim minority in China, are mainly located in the autonomous region of Xinjiang. The Chinese government has pursued an aggressive settlement policy in this region since 1949, with the percentage of Han Chinese in the region increasing from five to forty percent in the second half of the 20th century. Since 2014, the Uyghurs have been subject to persecution and re-education – various sources have estimated that at least one million...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...